CRISPR-based diagnostic SHERLOCK has been optimized for rapid use during viral outbreaks by research teams at Broad Institute of MIT and Harvard. The new tool updates SHELOCK which was first unveiled in 2017, to detect pathogens quickly and cheaply directly from body fluids. The study is published in the journal Science.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer